63 related articles for article (PubMed ID: 877349)
21. [Autonomous adenoma of the thyroid gland and radioiodine therapy].
Kuchar O; Kraft O
Vnitr Lek; 1987 Sep; 33(9):739-47. PubMed ID: 3672952
[No Abstract] [Full Text] [Related]
22. [Effectiveness of radioactive iodine in the treatment of toxic adenoma: results of our experience with a group of 17 patients and review of the literature].
Melián E; Cuellar L; Estopiñán V; Riobó P; Lara JI; Sánchez-Franco F
Med Clin (Barc); 1988 Mar; 90(9):366-8. PubMed ID: 3292865
[No Abstract] [Full Text] [Related]
23. Childhood thyroid cancer.
Nĕmec J; Silink K; Soumar J; Niederle B; Zeman V
Acta Univ Carol Med (Praha); 1975; 21(5-6):405-79. PubMed ID: 1229883
[No Abstract] [Full Text] [Related]
24. Ablation of nonmalignant thyroid remnants with low doses of radioactive iodine: concise communication.
Ramacciotti C; Pretorius HT; Line BR; Goldman JM; Robbins J
J Nucl Med; 1982 Jun; 23(6):483-9. PubMed ID: 7077401
[No Abstract] [Full Text] [Related]
25. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
Janisch A; Altenbrunn HJ; Markwardt J
Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
[No Abstract] [Full Text] [Related]
26. [Treatment of follicular thyroid cancer with radioiodine (author's transl)].
Dirr W; Pabst HW
Schweiz Rundsch Med Prax; 1982 Mar; 71(13):562-6. PubMed ID: 7079235
[No Abstract] [Full Text] [Related]
27. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant treatment of thyroid cancer.
Beauduin M; Hermans J; Majois F
Acta Otorhinolaryngol Belg; 1987; 41(5):944-5. PubMed ID: 3454107
[No Abstract] [Full Text] [Related]
29. [Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer].
Dietlein M; Dressler J; Farahati J; Leisner B; Moser E; Reiners C; Schicha H; Schober O
Nuklearmedizin; 1999; 38(6A):221-2. PubMed ID: 10510812
[No Abstract] [Full Text] [Related]
30. 131I dosimetry and thyroid stunning.
Gerard SK; Park HM
J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
[No Abstract] [Full Text] [Related]
31. Iodine-131 contamination from thyroid cancer patients.
Ibis E; Wilson CR; Collier BD; Akansel G; Isitman AT; Yoss RG
J Nucl Med; 1992 Dec; 33(12):2110-5. PubMed ID: 1460501
[TBL] [Abstract][Full Text] [Related]
32. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
33. Radiation safety considerations for post-iodine-131 thyroid cancer therapy.
Culver CM; Dworkin HJ
J Nucl Med; 1992 Jul; 33(7):1402-5. PubMed ID: 1613585
[TBL] [Abstract][Full Text] [Related]
34. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
[No Abstract] [Full Text] [Related]
35. Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment.
Al-Haj AN; Lagarde CS; Lobriguito AM
Health Phys; 2007 Dec; 93(6):656-66. PubMed ID: 17993846
[TBL] [Abstract][Full Text] [Related]
36. Aspects of timing and selection of cases in radioiodine therapy and percutaneous irradiation of well differentiated carcinoma of the thyroid.
Wiebe V; Schneider C; Franke HD
Strahlentherapie; 1975 Jan; 149(1):55-9. PubMed ID: 1124555
[TBL] [Abstract][Full Text] [Related]
37. [Thyroid carcinoma and pregnancy].
da Rosa JC; de Lima GR; Coradazzi ME; Shnaider J
Rev Paul Med; 1973 Jul; 82(1):1-6. PubMed ID: 4804030
[No Abstract] [Full Text] [Related]
38. Sialadenitis following iodine-131 therapy for thyroid carcinoma.
J Nucl Med; 1985 Jul; 26(7):816-7. PubMed ID: 4009293
[No Abstract] [Full Text] [Related]
39. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
[TBL] [Abstract][Full Text] [Related]
40. Prospect for the treatment of thyroid cancer with post-operative irradiation.
Liaw KY; Chang-Chien Y; Tzen KY; Chen CC; Huang SC; How SW; Chang CC; Chen FW
Taiwan Yi Xue Hui Za Zhi; 1981 Nov; 80(11):1240-52. PubMed ID: 6948920
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
